Literature DB >> 24966473

The challenge of triple negative breast cancers.

Kannan Vaidyanathan1.   

Abstract

Entities:  

Year:  2014        PMID: 24966473      PMCID: PMC4062668          DOI: 10.1007/s12291-014-0453-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


× No keyword cloud information.
  8 in total

Review 1.  Triple-negative breast cancer: disease entity or title of convenience?

Authors:  Lisa Carey; Eric Winer; Giuseppe Viale; David Cameron; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2010-09-28       Impact factor: 66.675

2.  The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis.

Authors:  Xin Du; Xiao-Qing Li; Lin Li; Yuan-Yuan Xu; Yu-Mei Feng
Journal:  Breast Cancer Res Treat       Date:  2013-02-10       Impact factor: 4.872

3.  ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women.

Authors:  K Vaidyanathan; P Kumar; C O Reddy; V Deshmane; K Somasundaram; G Mukherjee
Journal:  Indian J Cancer       Date:  2010 Jan-Mar       Impact factor: 1.224

4.  RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.

Authors:  C Denkert; S Loibl; R Kronenwett; J Budczies; C von Törne; V Nekljudova; S Darb-Esfahani; C Solbach; B V Sinn; C Petry; B M Müller; J Hilfrich; G Altmann; A Staebler; C Roth; B Ataseven; T Kirchner; M Dietel; M Untch; G von Minckwitz
Journal:  Ann Oncol       Date:  2012-11-06       Impact factor: 32.976

5.  Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.

Authors:  Ning Qing Liu; Christoph Stingl; Maxime P Look; Marcel Smid; René B H Braakman; Tommaso De Marchi; Anieta M Sieuwerts; Paul N Span; Fred C G J Sweep; Barbro K Linderholm; Anita Mangia; Angelo Paradiso; Luc Y Dirix; Steven J Van Laere; Theo M Luider; John W M Martens; John A Foekens; Arzu Umar
Journal:  J Natl Cancer Inst       Date:  2014-01-07       Impact factor: 13.506

6.  PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

Authors:  Roy R L Bastien; Álvaro Rodríguez-Lescure; Mark T W Ebbert; Aleix Prat; Blanca Munárriz; Leslie Rowe; Patricia Miller; Manuel Ruiz-Borrego; Daniel Anderson; Bradley Lyons; Isabel Álvarez; Tracy Dowell; David Wall; Miguel Ángel Seguí; Lee Barley; Kenneth M Boucher; Emilio Alba; Lisa Pappas; Carole A Davis; Ignacio Aranda; Christiane Fauron; Inge J Stijleman; José Palacios; Antonio Antón; Eva Carrasco; Rosalía Caballero; Matthew J Ellis; Torsten O Nielsen; Charles M Perou; Mark Astill; Philip S Bernard; Miguel Martín
Journal:  BMC Med Genomics       Date:  2012-10-04       Impact factor: 3.063

7.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

Review 8.  The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis.

Authors:  Elizabeth Anderson
Journal:  Breast Cancer Res       Date:  2002-07-24       Impact factor: 6.466

  8 in total
  1 in total

1.  Triple-Negative Breast Cancer with Dermatomyositis: A Case Report and Literature Review.

Authors:  Xiao Chen; Aoxiang Chen; Chaoqi Liu; Bin Zhang
Journal:  Cancer Manag Res       Date:  2022-02-15       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.